8.5154

0.98% -0.0846

Xeris Biopharma Holdings Inc (XERS)

Overview News Price History Option Chain Financials Discussions Forecast

Xeris Biopharma Holdings Inc stock is traded at $8.5154, with a volume of 752.32K. It is down -0.98% in the last 24 hours and down -3.23% over the past month. Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.

Previous Close:

$8.60

Open:

$8.45

24h Volume:

752.32K

Relative Volume:

0.42

Market Cap:

$1.55B

Revenue:

$314.85M

Net Income/Loss:

$12.01M

P/E Ratio:

130.01

EPS:

0.0655

Net Cash Flow:

$47.52M

1W Performance:

+6.58%

1M Performance:

-3.23%

6M Performance:

+23.24%

1Y Performance:

+10.89%

1-Day Range:

$8.2589

$8.535

1-Week Range:

$7.96

$8.70

52-Week Range:

$5.25

$10.08

Xeris Biopharma Holdings Inc Stock (XERS) Company Profile

Name

Xeris Biopharma Holdings Inc

Sector

Healthcare (1089)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

844-445-5704

Address

1375 WEST FULTON STREET, SUITE 1300, CHICAGO, IL

Employee

435

Twitter

@XerisPharma

Next Earnings Date

2026-08-06

Latest SEC Filings

XERS's Discussions on Twitter

Compare XERS vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XERS Xeris Biopharma Holdings Inc	8.505	1.57B	314.85M	12.01M	47.52M	0.0655
TAK Takeda Pharmaceutical Co Adr	17.36	56.30B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.48	42.85B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.59	42.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	72.73	30.49B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	506.96	21.43B	3.17B	1.29B	1.01B	27.09

Xeris Biopharma Holdings Inc Stock (XERS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-25	Initiated	Barclays	Overweight
Aug-12-25	Resumed	H.C. Wainwright	Buy
Nov-11-24	Downgrade	Piper Sandler	Overweight → Neutral
Mar-28-24	Initiated	Oppenheimer	Outperform
Aug-28-23	Initiated	Craig Hallum	Buy
Oct-21-22	Initiated	Jefferies	Buy
Apr-28-22	Initiated	Craig Hallum	Buy
Nov-17-21	Initiated	SVB Leerink	Outperform
Oct-29-21	Initiated	H.C. Wainwright	Buy
Apr-07-21	Resumed	RBC Capital Mkts	Outperform
Feb-18-20	Initiated	Piper Sandler	Overweight
Jul-16-18	Initiated	Jefferies	Buy
Jul-16-18	Initiated	Leerink Partners	Outperform
Jul-16-18	Initiated	RBC Capital Mkts	Outperform

View All

Xeris Biopharma Holdings Inc Stock (XERS) Latest News

Aug 15, 2026

Walleye Capital LLC Invests $4.84 Million in Xeris Biopharma Holdings, Inc. $XERS - marketbeat.com

Aug 15, 2026

Why Xeris Biopharma Holdings (XERS) Is Up 8.4% After Tightening 2026 Revenue Guidance And Advancing XP-8121 - Yahoo Finance

Aug 15, 2026

Aug 14, 2026

Xeris Biopharma Holdings (XERS) Posts Record Q2 Revenue, Is It Still A Bargain? - Yahoo Finance

Aug 14, 2026

XERS|Xeris Biopharma Holdings Inc|Price:8.322|Chg%:-0.168 - TradingKey

Aug 14, 2026

Aug 13, 2026

Mission Produce And Two Other Stocks Estimated To Be Trading Below Intrinsic Value - simplywall.st

Aug 13, 2026

Aug 12, 2026

Xeris Biopharma (NASDAQ:XERS) Insider Sells $42,500.00 in Stock - marketbeat.com

Aug 12, 2026

Xeris Biopharma (XERS) insider Steven Pieper plans Rule 144 sale of 20,000 shares - Stock Titan

Aug 12, 2026

Aug 11, 2026

HC Wainwright Comments on Xeris Biopharma FY2026 Earnings - marketbeat.com

Aug 11, 2026

Aug 10, 2026

Janus Henderson Group PLC Boosts Stock Holdings in Xeris Biopharma Holdings, Inc. $XERS - marketbeat.com

Aug 10, 2026

Renaissance Technologies LLC Cuts Stock Position in Xeris Biopharma Holdings, Inc. $XERS - marketbeat.com

Aug 10, 2026